Valuation: genOway

Market Cap 2.29Cr 2.62Cr 2.16Cr 1.96Cr 3.67Cr 251.62Cr 3.69Cr 26Cr 9.98Cr 127.93Cr 9.85Cr 9.63Cr 411.62Cr P/E 2024 *
-
P/E 2025 -
Enterprise Value 2.96Cr 3.39Cr 2.79Cr 2.54Cr 4.75Cr 325.54Cr 4.77Cr 33Cr 13Cr 165.51Cr 13Cr 12Cr 532.55Cr EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day+1.64%
1 week+0.40%
1 month+1.22%
3 months+5.53%
6 months+2.90%
Current year-8.49%
1 week 2.37
Extreme 2.37
2.5
1 month 2.37
Extreme 2.37
2.53
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 01/03/1999
Director of Finance/CFO - 01/10/2015
Director TitleAgeSince
Director/Board Member - 01/03/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
20/01/22 Buy

Chief Executive Officer

12,500 0.1376%
17/11/21 Sell

Chief Executive Officer

5,000 0.0553%
13/11/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
+1.64%+0.40%-13.29%-31.87% 2.62Cr
+0.11%+2.71%+0.44%+26.85% 4.63TCr
-1.12%+1.78%+42.30%+27.55% 4.39TCr
-3.04%-6.29%+338.56%+515.97% 4.09TCr
-0.74%+1.25%+4.92%+67.98% 3.99TCr
-0.50%+0.67%+10.29%+41.28% 2.95TCr
-0.46%+4.22%+22.81%+139.44% 1.71TCr
-0.97%-10.17% - - 1.55TCr
-0.57%+8.12%+22.19%+38.68% 1.52TCr
-3.14%+31.91%-11.79% - 1.4TCr
Average -0.88%+3.43%+46.27%+103.23% 2.62TCr
Weighted average by Cap. -1.10%+1.87%+68.03%+130.89%

Financials

2024 2025
Net sales 2.75Cr 3.16Cr 2.6Cr 2.36Cr 4.42Cr 302.96Cr 4.44Cr 31Cr 12Cr 154.03Cr 12Cr 12Cr 495.6Cr 2.86Cr 3.28Cr 2.7Cr 2.45Cr 4.59Cr 314.72Cr 4.61Cr 32Cr 12Cr 160.01Cr 12Cr 12Cr 514.85Cr
Net income 18.31L 20.99L 17.29L 15.7L 29.41L 20Cr 29.53L 2.07Cr 79.91L 10Cr 78.87L 77.12L 33Cr 9L 10.64L 9L 8L 14.9L 10Cr 14.97L 1.05Cr 40.49L 5.19Cr 39.97L 39.08L 17Cr
Net Debt 6L 7L 6L 5L 10.01L 6.86Cr 10.05L 70.46L 27.19L 3.49Cr 26.84L 26.24L 11Cr 67.18L 77.04L 63.44L 57.6L 1.08Cr 74Cr 1.08Cr 7.6Cr 2.93Cr 38Cr 2.89Cr 2.83Cr 120.94Cr
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
18/26/18 €2.480 +1.64% 4,727
17/26/17 €2.440 +2.95% 2,688
16/26/16 €2.370 -0.42% 1,094
15/26/15 €2.380 -2.46% 4,387
14/26/14 €2.440 -1.21% 1,408
  1. Stock Market
  2. Stocks
  3. ALGEN Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!